COMMUNIQUÉS West-GlobeNewswire

-
Momenta Pharmaceuticals Reports Second Quarter 2019 Financial and Operating Results
02/08/2019 -
Amicus Therapeutics Receives Marketing Authorization for Galafold® (migalastat) for Fabry Disease in Argentina
02/08/2019 -
Cronos Group Establishes New Growth Opportunity in the United States with Acquisition of Hemp-Based Products Platform
02/08/2019 -
Stemline Therapeutics Reports Second Quarter 2019 Financial Results
02/08/2019 -
Hemispherx Secures Corrections from Two Stock News Organizations Related to Their Inaccurate Reporting of an Equity Distribution Agreement Disclosed in a Recent SEC Filing
02/08/2019 -
Exactus Inc. Acquires Green Goddess - Launches CBD Brands and Acquires Manufacturing Capabilities
02/08/2019 -
Dentsply Sirona Reports Strong Second Quarter 2019 Results
02/08/2019 -
RadNet Expands its Efforts in Artificial Intelligence
02/08/2019 -
HMS Reports Second Quarter 2019 Financial Results
02/08/2019 -
Periodic update on transaction details related to Philips’ share repurchases
02/08/2019 -
Santhera Announces Closing of Licensing Transaction with Chiesi Group for Raxone® in LHON
02/08/2019 -
CORRECTING and REPLACING - Fluidigm Announces Second Quarter 2019 Financial Results
02/08/2019 -
CORRECTION - FibroGen to Report Second Quarter 2019 Financial Results on Thursday, August 8, 2019
02/08/2019 -
FibroGen to Report Second Quarter 2019 Financial Results on Thursday, August 8, 2019
02/08/2019 -
MannKind Corporation to Hold 2019 Second Quarter Financial Results Conference Call on August 7, 2019
01/08/2019 -
Kane Biotech Announces New Funding Granted from CanExport Program
01/08/2019 -
ARCA biopharma Announces Second Quarter 2019 Financial Results and Provides Corporate Update
01/08/2019 -
Eidos Therapeutics Reports Second Quarter 2019 Financial Results
01/08/2019 -
Osmotica Pharmaceuticals plc to Provide Second Quarter 2019 Business and Financial Update on August 8, 2019
01/08/2019
Pages